|
1
|
Siefker-Radtke A: Urachal adenocarcinoma:
A clinician's guide for treatment. Semin Oncol. 39:619–624. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang L, Zhou N, Xu H, Liu D, Lu Y, Li F
and Guo J: Urachal mucinous adenocarcinoma with pseudomyxoma
peritonei: A case report. Medicine (Baltimore). 96:e75482017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paras FA Jr and Maclennan GT: Urachal
adenocarcinoma. J Urol. 180:7202008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Das JP, Vargas HA, Lee A, Hutchinson B,
O'Connor E, Kok HK, Torreggiani W, Murphy J, Roche C, Bruzzi J and
McCarthy P: The urachus revisited: Multimodal imaging of benign
& malignant urachal pathology. Br J Radiol. 93:201901182020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ashley RA, Inman BA, Routh JC, Rohlinger
AL, Husmann DA and Kramer SA: Urachal anomalies: A longitudinal
study of urachal remnants in children and adults. J Urol.
178:1615–1618. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bruins HM, Visser O, Ploeg M,
Hulsbergen-van De Kaa CA, Kiemeney LALM and Witjes JA: The clinical
epidemiology of urachal carcinoma: Results of a large, population
based study. J Urol. 188:1102–1107. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siefker-Radtke AO, Gee J, Shen YU, Wen S,
Daliani D, Millikan RE and Pisters LL: Multimodality management of
urachal carcinoma: The M. D. Anderson cancer center experience. J
Urol. 169:1295–1298. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shao G, Xu C, Liu J, Li X, Li L, Li X,
Zhang X, Fan Y and Zhou L: Clinical, pathological, and prognostic
analysis of urachal carcinoma. Urol Int. 106:199–208. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wright JL, Porter MP, Li CI, Lange PH and
Lin DW: Differences in survival among patients with urachal and
nonurachal adenocarcinomas of the bladder. Cancer. 107:721–728.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Molina JR, Quevedo JF, Furth AF,
Richardson RL, Zincke H and Burch PA: Predictors of survival from
urachal cancer: A Mayo Clinic study of 49 cases. Cancer.
110:2434–2440. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Collins DC, Velázquez-Kennedy K, Deady S,
Brady AP, Sweeney P and Power DG: National incidence, management
and survival of urachal carcinoma. Rare Tumors. 8:62572016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zihni A, Gerull WD, Cavallo JA, Ge T, Ray
S, Chiu J, Brunt LM and Awad MM: Comparison of precision and speed
in laparoscopic and robot-assisted surgical task performance. J
Surg Res. 223:29–33. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franco A, Ditonno F, Manfredi C, Johnson
AD, Mamgain A, Feldman-Schultz O, Feng CL, Pellegrino AA, Mir MC,
Porpiglia F, et al: Robot-assisted surgery in the field of urology:
The most pioneering approaches 2015–2023. Res Rep Urol. 15:453–470.
2023.PubMed/NCBI
|
|
14
|
Spiess PE and Correa JJ: Robotic assisted
laparoscopic partial cystectomy and urachal resection for urachal
adenocarcinoma. Int Braz J Urol. 35:6092009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suartz CV, Martinez LM, Brito PH, Neto CV,
Cordeiro MD, Botelho LAA, Gallucci FP, Mota JM, Nahas WC and
Ribeiro-Filho LA: Robotic-assisted approaches to urachal carcinoma:
A comprehensive systematic review of the safety and efficacy
outcomes. BJUI Compass. 5:327–333. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Begg RC: The urachus: Its anatomy,
histology and development. J Anat. 64:170–183. 1930.PubMed/NCBI
|
|
17
|
Gopalan A, Sharp DS, Fine SW, Tickoo SK,
Herr HW, Reuter VE and Olgac S: Urachal carcinoma: A
clinicopathologic analysis of 24 cases with outcome correlation. Am
J Surg Pathol. 33:659–668. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sheldon CA, Clayman RV, Gonzalez R,
Williams RD and Fraley EE: Malignant urachal lesions. J Urol.
131:1–8. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ashley RA, Inman BA, Sebo TJ, Leibovich
BC, Blute ML, Kwon ED and Zincke H: Urachal carcinoma:
Clinicopathologic features and long-term outcomes of an aggressive
malignancy. Cancer. 107:712–720. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duan F, Zhai W, Zhang B and Guo S: Urachal
carcinoma: Impact of recurrence pattern and lymphadenectomy on
long-term outcomes. Cancer Med. 9:4166–4174. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J and Wu J: Options for diagnosis
and treatment of urachal carcinoma. Asia Pac J Clin Oncol.
9:117–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ke C, Hu Z and Yang C: Preoperative
accuracy of diagnostic evaluation of urachal carcinoma. Cancer Med.
12:9106–9115. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reis H, Krafft U, Niedworok C, Módos O,
Herold T, Behrendt M, Al-Ahmadie H, Hadaschik B, Nyirady P and
Szarvas T: Biomarkers in urachal cancer and adenocarcinomas in the
bladder: A comprehensive review supplemented by own data. Dis
Markers. 2018:73081682018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tiutiucă RC, Năstase Pușcașu AI, Țarcă E,
Stoenescu N, Cojocaru E, Trandafir LM, Țarcă V, Scripcariu DV and
Moscalu M: Urachal carcinoma, an unusual possibility of hematuria;
case report and literature review. Diagnostics (Basel).
12:18922022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanamaru T, Iguchi T, Yukimatsu N, Shimizu
Y, Kohyama Y, Tachibana H, Kato M, Yamasaki T, Tamada S and
Nakatani T: A case of metastatic urachal carcinoma treated with
FOLFIRI (irinotecan and 5-fluorouracil/leucovorin) plus
bevacizumab. Urol Case Rep. 3:9–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar R, Harilal S, Abdelgawad MA, Ghoneim
MM, Kumar A and Mathew B: Urachal carcinoma: The journey so far and
the road ahead. Pathol Res Pract. 243:1543792023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Monteiro V and Cunha TM: Urachal
carcinoma: Imaging findings. Acta Radiol Short Rep.
1:arsr.2011.110018. 2012.PubMed/NCBI
|
|
28
|
Machida H, Ueno E, Nakazawa H, Fujimura M
and Kihara T: Computed tomographic appearance of urachal carcinoma
associated with urachal diverticulum misdiagnosed by cystoscopy.
Abdom Imaging. 33:363–366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li S, Meng X, Liang P, Feng C, Shen Y, Hu
D and Li Z: Clinical and radiological features of urachal carcinoma
and infection. Front Oncol. 11:7021162021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kapoor R, Darasani N and Bansal A: Rare
presentation of urachal adenocarcinoma with skip metastasis to
colon. Indian J Urol. 32:244–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stokkel LE, Stokkel MPM, Donswijk ML,
Lahaye MJ, Bekers EM, Van Rhijn BWG and Mertens LS: The diagnostic
value of FDG-PET/CT for urachal cancer. Clin Genitourin Cancer.
19:373–380. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang HL, Lu DW, Yerian LM, Alsikafi N,
Steinberg G, Hart J and Yang XJ: Immunohistochemical distinction
between primary adenocarcinoma of the bladder and secondary
colorectal adenocarcinoma. Am J Surg Pathol. 25:1380–1387. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Herr HW, Bochner BH, Sharp D, Dalbagni G
and Reuter VE: Urachal carcinoma: Contemporary surgical outcomes. J
Urol. 178:74–78. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Knoedler JJ, Boorjian SA, Kim SP, Weight
CJ, Thapa P, Tarrell RF, Cheville JC and Frank I: Does partial
cystectomy compromise oncologic outcomes for patients with bladder
cancer compared to radical cystectomy? A matched case-control
analysis. J Urol. 188:1115–1119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dursun F, Lim K, Svatek RS, Xu J,
El-Zaatari ZM, Wenker EP, Klaassen ZW, Mansour AM, Muhammad T,
Efstathiou E, et al: Clinical outcomes and patterns of
population-based management of urachal carcinoma of the bladder: An
analysis of the national cancer database. Cancer Med. 11:4273–4282.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hamilou Z, North S, Canil C, Wood L, Hotte
S, Sridhar SS, Soulières D, Latour M, Taussky D, Kassouf W and
Blais N: Management of urachal cancer: A consensus statement by the
canadian urological association and genitourinary medical
oncologists of Canada. Can Urol Assoc J. 14:E57–E64.
2020.PubMed/NCBI
|
|
37
|
Jia Z, Chang X, Li X, Wang B and Zhang X:
Urachal carcinoma: Are lymphadenectomy and umbilectomy necessary?
Med Sci Monit. 26:e9279132020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Milhoua PM, Knoll A, Bleustein CB and
Ghavamian R: Laparoscopic partial cystectomy for treatment of
adenocarcinoma of the urachus. Urology. 67:423.e15–423.e17. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi Z: Laparoscopic vs open surgery: A
comparative analysis of wound infection rates and recovery
outcomes. Int Wound J. 21:e144742024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
James K, Vasdev N, Mohan-S G, Lane T and
Adshead JM: Robotic partial cystectomy for primary urachal
adenocarcinoma of the urinary bladder. Curr Urol. 8:183–188. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brassetti A, Ragusa A, Tedesco F, Prata F,
Cacciatore L, Iannuzzi A, Bove AM, Anceschi U, Proietti F,
D'Annunzio S, et al: Robotic Surgery in Urology: History from
PROBOT® to HUGOTM. Sensors (Basel).
23:71042023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schwaibold H, Wiesend F and Bach C: The
age of robotic surgery-is laparoscopy dead? Arab J Urol.
16:262–269. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Alemzadeh H, Raman J, Leveson N,
Kalbarczyk Z and Iyer RK: Adverse events in robotic surgery: A
retrospective study of 14 years of FDA data. PLoS One.
11:e01514702016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kirkpatrick T and LaGrange C: Robotic
surgery: Risks vs rewards. 2023.
|
|
45
|
Mylonas KS, O'Malley P, Ziogas IA,
El-Kabab L and Nasioudis D: Malignant urachal neoplasms: A
population-based study and systematic review of literature. Urol
Oncol. 35:33.e11–33.e19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen M, Xue C, Huang R, Ni MQ, Li L, Li
HF, Yang W, Hu AQ, Zheng ZS, An X and Shi Y: Treatment outcome of
different chemotherapy in patients with relapsed or metastatic
malignant urachal tumor. Front Oncol. 11:7391342021. View Article : Google Scholar : PubMed/NCBI
|
